2026 / 05 / 13
Exhibition and Presentation at
PEGS BOSTON
Ajinomoto Bio-Pharma Services will participate in PEGS BOSTON, on May 11 to 15, 2026.
PEGS BOSTON Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more.
Ajinomoto Bio-Pharma Services will be making luncheon and poster presentations and exhibiting its services and technologies at the conference.
We look forward to your visit.
| Event Name | PEGS BOSTON |
|---|---|
| Dates | May 11 (Mon) – 15 (Fri), 2026 |
| Venue | Omni Boston Hotel at the Seaport 450 Summer Street, Boston, MA 02210 |
| Exhibition | booth #105 |
Luncheon Presentation
| Title and Presenters | “Corynex Secretory Manufacturing for VHHs and Peptides: Extending Half-Life with PASylation” Presenter: Yumi Nagase, Lead Researcher, BioPharma Solutions, Ajinomoto Co. Inc., Presenter: Uli Binder, Managing Director, XL-protein GmbH |
|---|---|
| Abstract | Corynex is Ajinomoto’s gram-positive bacterial platform and CDMO service for biologics. This presentation highlights our capabilities and case studies for production of long-chain peptides and VHHs. To address the short half-life often associated with low-molecular-weight proteins, we combine Corynex with XL-protein’s PASylation technology to create half-life–extended biopharmaceuticals, achieving high titers with high purity through an endotoxin-free host and a secretion-based process. |
| Date, Time and Venue | Tuesday, May 12, 1:20 pm |
Poster Presentation (1)
| Session | POSTER SESSION A |
|---|---|
| Title and Presenters | B006 “A011 Corynex®: Scalable Secretion Service for Long-Chain Peptides Including GLP-1-Related Peptides, Presented by Makoto Kishi, Ajinomoto Co., Inc. |
Poster Presentation (2)
| Session | POSTER SESSION B |
|---|---|
| Title and Presenters | B007 Corynex® for Next-Generation VHHs: Site-Specific Conjugation via ncAA Incorporation and Half-Life Extension via PASylation®, Presented by Yumi Nagase, Ajinomoto Co., Inc. |
Poster Presentation (3)
| Session | POSTER SESSION C |
|---|---|
| Title and Presenters | C009 “AJICAP® Technology Expanding Therapeutic Windows of ADCs and Accelerating Development of Novel Antibody-Based Conjugates” Takumi Hosozawa, Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc. |